These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 32882715)

  • 1. Does Chronic Treatment with Oral Anticoagulants Ameliorate the Clinical Course of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Coronavirus Disease 2019 (COVID-19)?
    Harenberg J; Bauersachs R; Ageno W
    Semin Thromb Hemost; 2021 Jun; 47(4):338-340. PubMed ID: 32882715
    [No Abstract]   [Full Text] [Related]  

  • 2. [Factors Associated with Direct Oral Anticoagulants versus Vitamin K Antagonists in Patients with Non-valvular Atrial Fibrillation].
    Saliba L; Mondoly P; Duparc A; Bura-Rivière A; Maury P; Calmels V; Sallerin B; Pathak A; Montastruc JL; Bagheri H
    Therapie; 2015; 70(6):485-92. PubMed ID: 26223162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulation for COVID-19 Patients: A Bird's-Eye View.
    Kreidieh F; Temraz S
    Clin Appl Thromb Hemost; 2021; 27():10760296211039288. PubMed ID: 34595937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma Antithrombin Values Are Significantly Decreased in Coronavirus Disease 2019 (COVID-19) Patients with Severe Illness.
    Lippi G; Henry BM; Sanchis-Gomar F
    Semin Thromb Hemost; 2021 Jun; 47(4):460-462. PubMed ID: 33378783
    [No Abstract]   [Full Text] [Related]  

  • 5. Switching warfarin patients to a direct oral anticoagulant during the Coronavirus Disease-19 pandemic.
    Patel R; Czuprynska J; Roberts LN; Vadher B; Rea C; Patel R; Gee E; Saul G; Coles E; Brown A; Byrne R; Speed V; Patel JP; Arya R
    Thromb Res; 2021 Jan; 197():192-194. PubMed ID: 33227656
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of the short-term risk of bleeding and arterial thromboembolic events in nonvalvular atrial fibrillation patients newly treated with dabigatran or rivaroxaban versus vitamin K antagonists: a French nationwide propensity-matched cohort study.
    Maura G; Blotière PO; Bouillon K; Billionnet C; Ricordeau P; Alla F; Zureik M
    Circulation; 2015 Sep; 132(13):1252-60. PubMed ID: 26199338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct oral anticoagulants: to switch or not to switch?
    Lugthart S; Leebeek FW
    Neth J Med; 2015 Oct; 73(8):359-61. PubMed ID: 26478544
    [No Abstract]   [Full Text] [Related]  

  • 8. [New oral anticoagulants in patients with atrial fibrillation in a urban health center].
    Rodríguez Pérez L; Capilla Lozano F; Gallego Fuentes R; Buitrago F
    Med Clin (Barc); 2016 Mar; 146(6):280-1. PubMed ID: 26343157
    [No Abstract]   [Full Text] [Related]  

  • 9. Recanalization therapies in acute ischemic stroke patients: impact of prior treatment with novel oral anticoagulants on bleeding complications and outcome.
    Seiffge DJ; Hooff RJ; Nolte CH; Béjot Y; Turc G; Ikenberg B; Berge E; Persike M; Dequatre-Ponchelle N; Strbian D; Pfeilschifter W; Zini A; Tveiten A; Næss H; Michel P; Sztajzel R; Luft A; Gensicke H; Traenka C; Hert L; Scheitz JF; De Marchis GM; Bonati LH; Peters N; Charidimou A; Werring DJ; Palm F; Reinhard M; Niesen WD; Nagao T; Pezzini A; Caso V; Nederkoorn PJ; Kägi G; von Hessling A; Padjen V; Cordonnier C; Erdur H; Lyrer PA; Brouns R; Steiner T; Tatlisumak T; Engelter ST;
    Circulation; 2015 Sep; 132(13):1261-9. PubMed ID: 26232277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of NOAC in orthopaedic surgery - pros and cons].
    Carling M; Eriksson B
    Lakartidningen; 2018 Dec; 115():. PubMed ID: 30512143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct oral anticoagulants and cancer-associated VTE: good for all, or just some?
    Carrier M; Wang TF
    Blood; 2020 Aug; 136(6):669-673. PubMed ID: 32575112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct oral anticoagulants: An update.
    Franco Moreno AI; Martín Díaz RM; García Navarro MJ
    Med Clin (Barc); 2018 Sep; 151(5):198-206. PubMed ID: 29295790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH.
    Kaatz S; Ahmad D; Spyropoulos AC; Schulman S;
    J Thromb Haemost; 2015 Nov; 13(11):2119-26. PubMed ID: 26764429
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical profile and prognosis in patients on oral anticoagulation before admission for COVID-19.
    Rivera-Caravaca JM; Núñez-Gil IJ; Vivas D; Viana-Llamas MC; Uribarri A; Becerra-Muñoz VM; Trabattoni D; Fernández Rozas I; Feltes G; López-Pais J; El-Battrawy I; Macaya C; Fernandez-Ortiz A; Estrada V; Marín F;
    Eur J Clin Invest; 2021 Jan; 51(1):e13436. PubMed ID: 33080051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19): Part II.
    Favaloro EJ; Lippi G
    Semin Thromb Hemost; 2021 Jun; 47(4):333-337. PubMed ID: 34062596
    [No Abstract]   [Full Text] [Related]  

  • 16. Direct Oral Anticoagulants in Patients With Inherited Thrombophilia and Venous Thromboembolism: A Prospective Cohort Study.
    Campello E; Spiezia L; Simion C; Tormene D; Camporese G; Dalla Valle F; Poretto A; Bulato C; Gavasso S; Radu CM; Simioni P
    J Am Heart Assoc; 2020 Dec; 9(23):e018917. PubMed ID: 33222589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-Vitamin K Oral Anticoagulants for Stroke Prevention in Special Populations with Atrial Fibrillation.
    Bisson A; Angoulvant D; Philippart R; Clementy N; Babuty D; Fauchier L
    Adv Ther; 2017 Jun; 34(6):1283-1290. PubMed ID: 28493056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bridging therapy in oral anticoagulated patients: focusing on how to do it.
    Palareti G
    Intern Emerg Med; 2007 Dec; 2(4):247-9. PubMed ID: 18172591
    [No Abstract]   [Full Text] [Related]  

  • 19. Factor Xa inhibitors in the prevention of cancer-related venous thromboembolism: lessons learned by clinical trials.
    Lavalle C; V Mariani M; Fedele F
    Future Oncol; 2020 Nov; 16(32):2591-2594. PubMed ID: 32805155
    [No Abstract]   [Full Text] [Related]  

  • 20. [Not Available].
    Själander S; Själander A
    Lakartidningen; 2018 Dec; 115():. PubMed ID: 30512136
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.